Kegoratile Aphane did not flinch when the needle pierced the skin of her right buttock, injecting a yellow-coloured drug touted as a revolution that could end the HIV pandemic.
The 32-year-old was among the very first South Africans, and Africans to receive a dose of lenacapavir, a drug taken twice a year that has been shown to reduce the risk of HIV transmission by more than 99.9 percent, making it functionally akin to a powerful vaccine.
“I didn’t even feel any pain,” she sa
Continue Reading on The Guardian Nigeria
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.